Market Closed - OTC Markets 14:40:24 2021-10-19 EDT 5-day change 1st Jan Change
0.000500 USD +400.00% Intraday chart for Viropro Inc. +400.00% +1,983.33%
1 day+400.00%
1 week+400.00%
Current month+400.00%
1 month+400.00%
3 months+49,900.00%
6 months+1,983.33%
Current year+1,983.33%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.01
Change 5-day change 1-year change 3-year change Capi.($)
+400.00%+400.00%+49,900.00%+49,900.00% 127K
+8.49%+20.55%+70.77%+103.07% 68.12B
-1.00%+4.57%+36.51%+65.25% 55.18B
-1.09%+32.96%+19.67%+509.20% 28.63B
+0.57%+18.87%+55.18%+5.18% 23.99B
+2.72%+3.41%-16.11%-12.04% 23.53B
-1.74%+6.47%+44.79%-23.64% 18.45B
-2.04%+10.84%+31.01%+628.97% 16.44B
-3.88%+16.98%+199.30%+350.94% 15.83B
+3.58%+1.96%+43.35%+162.22% 13.4B
Average +40.55%+10.51%+5,038.45%+5,168.91% 26.36B
Weighted average by Cap. +1.85%+13.10%+50.92%+161.93%
Logo Viropro Inc.
Viropro, Inc. is engaged in the development and manufacturing of biopharmaceutical drugs. The Company conducts operations primarily through its subsidiary, Alpha Biologics Sdn Bhd (Alpha) located in Penang, Malaysia. The Company intends to offer solution to the biopharma industry from drug concept through to product manufacturing. The Alpha facility consists of approximately 50,000 square feet of research and production space. The Alpha facility is designed to support the scale-up and manufacture of monoclonal antibodies.
Employees
-
  1. Stock Market
  2. Stocks
  3. VPRO Stock